Tuberculosis and HIV Product
Our Tuberculosis & HIV Products are formulated to support the effective treatment and long-term management of tuberculosis and HIV infections. Manufactured under stringent quality standards, they ensure safety, efficacy, and consistent performance. We provide reliable pharmaceutical solutions trusted by healthcare professionals to improve treatment outcomes, enhance patient care, and support global efforts in the fight against infectious diseases.
| Sr. No. | Composition |
|---|---|
| 1. | Entecavir IP 0.5 mg HEPITAISIS Tablet |
| 2. | Isoniazid IP 100 mg (inactive) tuberculosis (TB) infections Tablet |
| 3. | Isoniazid IP 300 mg (inactive) tuberculosis (TB) infections Tablet |
| 4. | Isoniazid IP 50 mg (inactive) tuberculosis (TB) infections Tablet |
| 5. | L-Orithine- L-Aspartate 150 mg and Pancreatin 100mg HEPITIC Tablet |
| 6. | Pyrazinamide IP 1000 mg Tablet |
| 7. | Pyrazinamide IP 250 Mg (TBC bactericidal antibiotic) Tablet |
| 8. | Pyrazinamide IP 500 mg Tablet |
| 9. | Pyrazinamide IP 750 mg Tablet |
| 10. | Tenofovir Fumarate IP 300mg , Lamivudine 300 mg , &Efavirenz IP 600 mg (HIV) Tablet |
| 11. | TenofovirDisoproxil Fumarate IP 300 mg & Lamivudine IP 300 mg (HIV) Tablet |